1,056 resources
Start Prev Rows 800 - 1000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
smart.who.int.hiv | R4 | HIV.B.DE256 | Gonorrhoea test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE808 | Gonorrhoea test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE312 | STI test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE864 | STI test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE325 | Confirmatory STI test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE877 | Confirmatory STI test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE149 | Maternal syphilis test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE250 | Syphilis test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE802 | Syphilis test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE70 | Syphilis test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE691 | Cervical cancer colposcopy result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE697 | Cervical cancer histopathology result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE179 | Intimate partner violence enquiry results ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE255 | Asymptomatic bacteriuria (ASB) test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE44 | HIV self-test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE259 | Urine protein test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE237 | STI tested for ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE956 | TB screening algorithm ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE673 | Cervical cytology screening test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE668 | VIA cervical cancer screening test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE201 | Adverse event severity ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE25 | Sex ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE259 | Risk factors, comorbidities and coinfections signs and symptoms ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE17 | Signs of serious illness ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE36 | Signs of substantial risk of HIV infection ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE155 | Signs of substantial risk of HIV infection ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE17 | Source of information ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE18 | Entry point for community-level testing ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE22 | Entry point for facility-level testing ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE746 | Entry point for facility-level testing ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE893 | Staging of liver disease ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE46 | Acute HIV infection symptoms ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE973 | Symptoms of TB ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE226 | Syndrome/STI diagnosed ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE778 | Syndrome/STI diagnosed ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1010 | TB treatment regimen composition ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE104 | Maternal HIV test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE688 | HPV16/18 test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE136 | Partner HIV status (confirmed) ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.PRV.DE11 | HIV status of contact ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE33 | Partner HIV status (reported) ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE141 | Maternal HIV status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE145 | Maternal HIV status at first ANC visit ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE132 | Partner HIV test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE78 | Alternative first-line ART regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE81 | Alternative second-line ART regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE603 | Vaccine brand ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.B.DE68 | HIV serotype ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE24 | Experience with PrEP ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE31 | PEP history ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE75 | Current ART regimen ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE66 | HIV diagnosing facility ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE79 | First-line ART regimen under special circumstances ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.E.DE240 | Cause of death of infant ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE88 | Assay number in testing strategy ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE194 | Assay number in testing strategy ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE82 | Optimal regimen for transition ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.H.DE41 | HIV treatment outcome ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE234 | HIV-exposed infant reason for unknown final status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE77 | Preferred first-line ART regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE80 | Preferred second-line ART regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.H.DE1 | Reason for follow-up ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE111 | HIV test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE94 | Test result of HIV assay 1 ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE200 | Test result of HIV assay 1 ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE216 | Test result of syphilis assay 1 ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE220 | Test result of syphilis assay 1 repeated ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE106 | Test result of HIV assay 1 repeated ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE212 | Test result of HIV assay 1 repeated ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE98 | Test result of HIV assay 2 ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE204 | Test result of HIV assay 2 ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE102 | Test result of HIV assay 3 ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE208 | Test result of HIV assay 3 ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE606 | Vaccination location ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE992 | TB diagnostic test category ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE50 | Key population member type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE114 | Key population member type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE67 | Place of delivery ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE13 | HIV viral load specimen type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE62 | Preterm birth status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE75 | Cause of death of mother ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE43 | Administrative Area ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE383 | Time to start ART ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE55 | Sex partner's HIV treatment status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE719 | Treatment method for cervical precancer lesions ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE764 | DSD ART model(s) ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE81 | HIV test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE168 | HIV test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1028 | TPT regimen type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE207 | Type of adverse VMMC event ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE709 | Cervical cancer diagnosis ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE658 | Cervical cancer primary screening test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE138 | Condom type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE284 | Chlamydia trachomatis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE836 | Chlamydia trachomatis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE853 | Herpes simplex virus (HSV) test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE306 | Mycoplasma genitalium test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE858 | Mycoplasma genitalium test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE276 | Neisseria gonorrhoeae test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE828 | Neisseria gonorrhoeae test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE293 | Trichomonas vaginalis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE845 | Trichomonas vaginalis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE301 | Herpes simplex virus (HSV) test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE821 | Syphilis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE269 | Syphilis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE55 | Syphilis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE191 | Type of follow-up appointment ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE125 | Type of follow-up appointment ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE264 | Type of hypertensive disorder ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE182 | HCV medicine type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE261 | Type of specimen ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE813 | Type of specimen ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE317 | Confirmatory syphilis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE869 | Confirmatory syphilis test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE466 | Type of treatment-limiting toxicity ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE681 | Cervical cancer triage test type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE604 | Vaccine type ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE610 | Disease targeted ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE107 | Sex factor for estimating creatinine clearance ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE358 | Clinical stage at start of ART ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE186 | HIV clinical stage ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE11 | PrEP dosing type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE61 | HIV exposure type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE204 | Timing of adverse event ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE41 | Timing of ART initiation ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE142 | Counselling provided ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE56 | Antiretroviral (ARV) drugs received prior to enrolment ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE15 | Testing entry point ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE136 | Type of iron supplement dosage provided ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE43 | ART start type ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE108 | Infant or child exposure to HIV ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE391 | Reason for HIV viral load test ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE525 | Type of follow-up appointment ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE17 | Past pregnancy complications ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1 | Reason for visit ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE143 | HIV self-test distributed for use by ValueSet | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Cholera.WC | IMMZ.D2.DT.Cholera.WC ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Cholera.rBS2to5 | IMMZ.D2.DT.Cholera.rBS2to5 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Cholera.rBSover5 | IMMZ.D2.DT.Cholera.rBSover5 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Dengue.NoScreen | IMMZ.D2.DT.Dengue.NoScreen ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Dengue.Seropos | IMMZ.D2.DT.Dengue.Seropos ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.HepatitisA.IHAV1 | IMMZ.D2.DT.HepatitisA.IHAV1 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.HepatitisA.IHAV2 | IMMZ.D2.DT.HepatitisA.IHAV2 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.HepatitisA.LHAV1 | IMMZ.D2.DT.HepatitisA.LHAV1 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Malaria.4Dose | IMMZ.D2.DT.Malaria.4Dose ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Meningococcal.MenA1 | IMMZ.D2.DT.Meningococcal.MenA1 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Meningococcal.MenA2 | IMMZ.D2.DT.Meningococcal.MenA2 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Meningococcal.MenC | IMMZ.D2.DT.Meningococcal.MenC ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Meningococcal.Poly | IMMZ.D2.DT.Meningococcal.Poly ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Meningococcal.Quad1 | IMMZ.D2.DT.Meningococcal.Quad1 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Meningococcal.Quad2 | IMMZ.D2.DT.Meningococcal.Quad2 ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Mumps.2Dose | IMMZ.D2.DT.Mumps.2Dose ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Rabies.PrEP | IMMZ.D2.DT.Rabies.PrEP ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Seasonalinfluenza.2Dose | IMMZ.D2.DT.Seasonalinfluenza.2Dose ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Varicella.1Dose | IMMZ.D2.DT.Varicella.1Dose ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D2.DT.Varicella.2Dose | IMMZ.D2.DT.Varicella.2Dose ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.Dengue.CI | IMMZ.D5.DT.Dengue.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.HepatitisA.CI | IMMZ.D5.DT.HepatitisA.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.Malaria.CI | IMMZ.D5.DT.Malaria.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.Meningococcal.CI | IMMZ.D5.DT.Meningococcal.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.Mumps.CI | IMMZ.D5.DT.Mumps.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.Rabies.CI | IMMZ.D5.DT.Rabies.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.Seasonalinfluenza.CI | IMMZ.D5.DT.Seasonalinfluenza.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D5.DT.Varicella.CI | IMMZ.D5.DT.Varicella.CI ValueSet for Decision Table | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE1 | IMMZ.Z.DE1 ValueSet for BCG vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE26 | IMMZ.Z.DE26 ValueSet for COVID-19 vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE2 | IMMZ.Z.DE2 ValueSet for Cholera vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE86 | IMMZ.D.DE86 ValueSet for Client education and counselling on immunization | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.I.DE48 | IMMZ.I.DE48 ValueSet for Closed stock discarded type | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE24 | IMMZ.Z.DE24 ValueSet for DTP-containing vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE241 | IMMZ.D.DE241 ValueSet for Dengue serostatus | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE25 | IMMZ.Z.DE25 ValueSet for Dengue vaccines | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE3 | IMMZ.Z.DE3 ValueSet for Diphtheria-containing vaccines | active | 2025-07 | atc internal sct loinc | |||
smart.who.int.immunizations | R4 | IMMZ.I.DE30 | IMMZ.I.DE30 ValueSet for Disaggregation group | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE126 | IMMZ.D.DE126 ValueSet for Disease targeted | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE204 | IMMZ.D.DE204 ValueSet for HIV status | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE7 | IMMZ.Z.DE7 ValueSet for HPV vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE5 | IMMZ.Z.DE5 ValueSet for Hepatitis A-containing vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE6 | IMMZ.Z.DE6 ValueSet for Hepatitis B-containing vaccines | active | 2025-07 | atc internal sct loinc | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE4 | IMMZ.Z.DE4 ValueSet for Hib-containing vaccines | active | 2025-07 | atc internal sct loinc | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE1 | IMMZ.D.DE1 ValueSet for Immunization event status | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE156 | IMMZ.D.DE156 ValueSet for Immunization recommendation status | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE31 | IMMZ.Z.DE31 ValueSet for Inactivated polio vaccines | active | 2025-07 | atc internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE8 | IMMZ.Z.DE8 ValueSet for JE vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE27 | IMMZ.Z.DE27 ValueSet for Malaria vaccines | active | 2025-07 | atc internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE32 | IMMZ.Z.DE32 ValueSet for Measles and rubella-containing vaccines | active | 2025-07 | atc internal loinc | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE9 | IMMZ.Z.DE9 ValueSet for Measles-containing vaccines | active | 2025-07 | atc internal sct loinc | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE10 | IMMZ.Z.DE10 ValueSet for Meningococcal vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE11 | IMMZ.Z.DE11 ValueSet for Mumps-containing vaccines | active | 2025-07 | atc internal sct loinc | |||
smart.who.int.immunizations | R4 | IMMZ.D.Observation | IMMZ.D.Observation ValueSet for Sex | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE30 | IMMZ.Z.DE30 ValueSet for Oral polio vaccines | active | 2025-07 | atc internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE29 | IMMZ.Z.DE29 ValueSet for Pentavalent vaccines | active | 2025-07 | atc internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE12 | IMMZ.Z.DE12 ValueSet for Pertussis-containing vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE13 | IMMZ.Z.DE13 ValueSet for Pneumococcal vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE14 | IMMZ.Z.DE14 ValueSet for Poliovirus-containing vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE161 | IMMZ.D.DE161 ValueSet for Potential contraindications | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.Z.DE15 | IMMZ.Z.DE15 ValueSet for Rabies vaccines | active | 2025-07 | atc internal sct | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE95 | IMMZ.D.DE95 ValueSet for Reaction manifestation | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE115 | IMMZ.D.DE115 ValueSet for Reaction outcome | active | 2025-07 | internal | |||
smart.who.int.immunizations | R4 | IMMZ.D.DE5 | IMMZ.D.DE5 ValueSet for Reason vaccine was not administered | active | 2025-07 | internal |